DROXIA
HYDROXYUREA
- Strength
- 300 mg/1
- Form
- Capsule
- Class
- Antimetabolite
H2-Pharma LLC
DROXIA
Hydroxyurea
Listed by Waylis Therapeutics LLC
- Strength
- 300 mg/1
- Form
- Capsule
- Route
- Oral
- Class
- Antimetabolite
What it contains
- Hydroxyurea 300 mg/1
FDA record
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Antimetabolite |
| Approval route | NDA — original brand approval |
| NDC code | 80725-830 |
| FDA application | NDA016295 |
| RxNorm concept | 200342 |
| Package sizes listed | 1 |
| Marketed since | September 2025 |
Other products containing Hydroxyurea
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
DROXIA
HYDROXYUREA
- Strength
- 400 mg/1
- Form
- Capsule
- Class
- Antimetabolite
H2-Pharma LLC
DROXIA
Hydroxyurea
- Strength
- 400 mg/1
- Form
- Capsule
- Class
- Antimetabolite
Waylis Therapeutics LLC
DROXIA
Hydroxyurea
- Strength
- 200 mg/1
- Form
- Capsule
- Class
- Antimetabolite
Waylis Therapeutics LLC
DROXIA
HYDROXYUREA
- Strength
- 200 mg/1
- Form
- Capsule
- Class
- Antimetabolite
H2-Pharma LLC
HYDREA
HYDROXYUREA
- Strength
- 500 mg/1
- Form
- Capsule
- Class
- Antimetabolite
H2-Pharma LLC
HYDREA
Hydroxyurea
- Strength
- 500 mg/1
- Form
- Capsule
- Class
- Antimetabolite
Waylis Therapeutics LLC
HYDROXYUREA
- Strength
- 500 mg/1
- Form
- Capsule
- Class
- Antimetabolite
Teva Pharmaceuticals USA, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.